TOLREMO therapeutics AG is a company that provides Drug resistance, Cancer therapy, Small molecule and more. TOLREMO therapeutics AG is headquartered in Switzerland ZURICH. TOLREMO therapeutics AG was founded in 2017. TOLREMO therapeutics AG has a total of 40 patents
TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.The company's molecules specifically...
What is TOLREMO therapeutics AG's official website?